Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
MetP Pharma AG, leveraging the proprietary nose-to-brain drug delivery technology BrainDos™ in internal and external product development and manufacturing programs, today announced promising preclinical research results that strongly support the ...
read more
SGS announced the company will implement the Veeva Vault CTMS across its network of clinical operations sites for the management of its global clinical study services.
read more
Vetter has moved into its new headquarters in Ravensburg, Germany.
read more
Bora Pharmaceuticals Co., Ltd. announced that it has completed the acquisition of Upsher-Smith Laboratories, a generics manufacturer and marketer based in Minnesota, U.S., from its sellers, Sawai Group Holdings and Sumitomo Corporation of Americas.
read more
CURE announced it has received their first purchase order from their recently announced agreement with Meroven for the development of OTF delivery for several molecules.
read more
BioVectra announced a five-year, $144.6 million (CAD) expansion project to enhance its Biopharmaceutical capabilities in both Charlottetown, Prince Edward Island and Windsor, Nova Scotia.
read more
Wednesday, December 09, 2020
SGS has announced the recruitment of the first participants in the US who will be taking part in a multinational clinical trial of a potential drug candidate for those suffering with COVID-19 related respiratory failure.
read more
– Exco InTouch, the leading provider of digital patient engagement and data capture solutions for clinical research and healthcare providers, today announced that its mDNA® technology project team have been shortlisted for the “Best Technological ...
read more
Merck announced the successful completion of the cash tender offer, through a subsidiary, for all of the outstanding shares of common stock of ArQule at a purchase price of $20.00 per share.
read more
Thursday, August 03, 2023
Mind Medicine announced that it has entered into a license agreement with Catalent to access the company’s proprietary Zydis® orally disintegrating tablet (ODT) technology.
read more
Trans-Hit Bio announced the signing of an exclusive partnership with Professor Hugo A. Barrera-Saldaña, Founder and General Director of Vitagenesis, the first Mexican biomarker-based diagnostic laboratory.
read more
Thursday, February 27, 2014
Sciformix Corporation, a leading Scientific Process Organization (SPO), has announced its presentation of novel practices in labeling management at the 2nd Annual Pharma Labeling Compliance Conference taking place March 19th-20th in Boston, MA. Bindu...
read more
Thursday, September 17, 2015
Amgen and Dezima Pharma B.V. have entered into a definitive acquisition agreement under which Amgen will acquire Dezima, a privately-held, Netherlands-based biotechnology company focused on developing innovative treatments for dyslipidemia.
read more
Monday, February 08, 2016
Nuvo Research has agreed with Horizon Pharma to extend the term of their manufacturing agreement for the production of PENNSAID® 2% for the U.S. market to December 31, 2029, which extends the agreement by an additional seven years.
read more
Paragon Bioservices, Inc., has announced that Mark Adams has joined the company as Vice President of Project Management. Mr. Adams will be responsible for directing Paragon’s Project Management team.
read more